A nature article was published this week describing how flavokawain A (FKA, a chalcone found in kava) interacts with S phase kinase-associated protein 2 (SKP2), which is known to play a key role in cancer progression and metastasis. The major finding was that FKA exerts its anti-metastatic effect in osteosarcoma by suppressing SKP2.
Notable points from the article:
FKA is minimally toxic to healthy tissues and organs.
SKP2 over-expression is associated with increased cancer progression, metastasis, and poorer survival rates in multiple cancers.
SKP2 inhibition is associated with improved outcomes.
Experimental Knockdown (gene therapy) of SKP2 is associated with improved cancer survival in vivo and in vitro.
FKA was demonstrated to inhibit SKP2 in vivo and in vitro.
This figure in the article was striking.
Notable points from the article:
FKA is minimally toxic to healthy tissues and organs.
SKP2 over-expression is associated with increased cancer progression, metastasis, and poorer survival rates in multiple cancers.
SKP2 inhibition is associated with improved outcomes.
Experimental Knockdown (gene therapy) of SKP2 is associated with improved cancer survival in vivo and in vitro.
FKA was demonstrated to inhibit SKP2 in vivo and in vitro.
This figure in the article was striking.